메뉴 건너뛰기




Volumn 139, Issue 7, 2003, Pages 943-944

Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream [5]

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; IMIQUIMOD; INTERLEUKIN 12;

EID: 0041307300     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.7.943     Document Type: Letter
Times cited : (57)

References (5)
  • 1
    • 0033823434 scopus 로고    scopus 로고
    • Immune-response modifiers: A new paradigm in the treatment of human papilloma virus
    • Tyring SK. Immune-response modifiers: a new paradigm in the treatment of human papilloma virus. Curr Ther Res Clin Exp. 2000;61:584-596.
    • (2000) Curr Ther Res Clin Exp , vol.61 , pp. 584-596
    • Tyring, S.K.1
  • 2
    • 0032694077 scopus 로고    scopus 로고
    • Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
    • Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol. 1999;41:1002-1007.
    • (1999) J Am Acad Dermatol , vol.41 , pp. 1002-1007
    • Beutner, K.R.1    Geisse, J.K.2    Helman, D.3    Fox, T.L.4    Ginkel, A.5    Owens, M.L.6
  • 5
    • 0033743997 scopus 로고    scopus 로고
    • Imiquimod: A novel treatment for lentigo maligna
    • Ahmed I, Berth-Jones. Imiquimod: a novel treatment for lentigo maligna. Br J Dermatol. 2000;143:843-845.
    • (2000) Br J Dermatol , vol.143 , pp. 843-845
    • Ahmed, I.1    Berth-Jones2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.